EUCTR2007-003627-20-GB进行中（未招募）1 期
Comparative Relative Lung Bioavailability of HFA-Seretide via spacer devices in healthy volunteers - Lung Bioavailability of HFA-Seretide via spacers
niversity of Dundee, Research & Innovation Services0 个研究点目标入组 20 人开始时间: 2008年12月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Healthy Volunteers
- •2.Male or female 18-65
- •3.Informed Consent
- •4.Ability to comply with the requirements of the protocol
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.No respiratory disease
- •3.Recent respiratory tract infection (2 months).
- •4.Any other clinically significant medical condition such as unstable angina, acute myocardial infarction in the preceding 3 months, recent TIA/ CVA,that may endanger the health or safety of the participant, or jeopardise the protocol.
- •5.Any significant abnormal laboratory result as deemed by the investigators
- •6.Pregnancy, planned pregnancy or lactation
- •7.Known or suspected contra-indication to any of the IMP’s
- •8.Concomitant use of medicines (prescribed, over the counter or herbal) that may interfere with the trial
研究者
相似试验
进行中（未招募）
1 期
COMPARATIVE LUNG BIOAVAILABILITY OF HFA-SERETIDE VIA SPACER DEVICES IN HEALTHY VOLUNTEERS - Systemic bioavailability of Seretide via spacer devicesBronchial AsthmaEUCTR2006-001104-36-GBniversity of Dundee (Research & Innovation Services)20
进行中（未招募）
1 期
Comparative study of the bioactivity of the HFA Fluticasone Dipropionate via current delivery devices - Systemic bioactivity of fluticasone via current delivery devices. Ver 1Bronchial AsthmaEUCTR2005-004475-37-GBniversity of Dundee ( Research & Innovation Services)20
已完成
1 期
A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal BlockAsthmaCOPDNCT04494321Intech Biopharm Ltd.99
已完成
不适用
Comparison of the relative bioavailability of ß-caryophyllene from two different formulations - a randomized, double-blind cross-over study in healthy subjectsHealthy men and womenDRKS00020461Vesifact AG24
已完成
1 期
A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal BlockChronic Obstructive Pulmonary Disease (COPD)AsthmaNCT02850484Intech Biopharm Ltd.99